158977 - Cabrini GP Lecture Series 2019 - Term 2 Lecture 1 Topic: Diet, obesity, inflammation and the gut microbiome - the implications for cancer prevention and response to immunotherapy treatments. e learning.
- : Online
This online video of Cabrini's GP Lecture is available for GP's via https://praxhub.com, at no cost. The lecture entitled Diet, obesity, inflammation and the gut microbiome - the implications for cancer prevention and response to immunotherapy treatments is designed to update GP’s on the scientific foundations for the latest cancer prevention guidelines and the emerging link of the role of diet and the microbiome has especially in the management of chemotherapy and immune based therapies.Relevance to General Practice
Cancer is a common disease & a major health problem in Australia today. At current rates, it is expected 1 in 2 Australians will be diagnosed with cancer by the age of 85. Cancer costs more than $4.5 billion in direct health system costs. GPs have a crucial role in the diagnosis & management of cancer. Immunotherapy is a type of cancer treatment which assists the body's immune system to fight cancer. Emerging data is relating diet & a healthy gut microbiome to cancer treatments. Important characteristics (of a healthy gut) are a microbiome with high levels of diversity, stability, resistance to stress-related change (antibiotics, infections, immunosuppression) and a high level of redundancy of metabolic pathways. Primary care plays an important role across the cancer continuum: in primary cancer prevention, discussing and delivering cancer screening tests, accurately diagnosing people with cancer when they present in the community, providing supportive care during and after treatmentLearning outcomes